These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 5107437)

  • 21. Screening and immunization of rubella-susceptible women. Experience in a large, prepaid medical group.
    Shlian DM
    JAMA; 1978 Aug; 240(7):662-3. PubMed ID: 671687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rubella vaccines.
    Healy A
    J Iowa Med Soc; 1970 Dec; 60(12):828 passim. PubMed ID: 5483844
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunologic response, virus excretion, and joint reactions with rubella vaccine. A study of adolescent girls and young women given live attenuated virus vaccine (HPV-77:DE-5).
    Lerman SJ; Nankervis GA; Heggie AD; Gold E
    Ann Intern Med; 1971 Jan; 74(1):67-73. PubMed ID: 4923805
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of rubella virus vaccine in children and in women of child-bearing age.
    Med Lett Drugs Ther; 1969 Oct; 11(22):90-2. PubMed ID: 5375101
    [No Abstract]   [Full Text] [Related]  

  • 25. Important assumptions, extrapolations, and established facts which underlie the use of live rubella virus vaccines.
    Leedom JM; Wilkins J; Portnoy B; Salvatore MA
    Am J Epidemiol; 1970 Sep; 92(3):151-7. PubMed ID: 5458941
    [No Abstract]   [Full Text] [Related]  

  • 26. Rubella vaccination. A review of practical experience.
    Meyer HM; Parkman PD
    JAMA; 1971 Jan; 215(4):613-9. PubMed ID: 5107438
    [No Abstract]   [Full Text] [Related]  

  • 27. Rubella vaccine for adolescents and young adults.
    Stephenson JR
    JAMA; 1970 Aug; 213(6):1040. PubMed ID: 5468182
    [No Abstract]   [Full Text] [Related]  

  • 28. [Systematic serodiagnosis of rubella in pregnancy and post-partum vaccination (HPV 77 vaccine)].
    Papiernik-Berkhauer E; Boué A; Lévy S
    Gynecol Obstet (Paris); 1969; 68(3):289-96. PubMed ID: 4187686
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical laboratory evaluation of rubella virus vaccine given to postpartum women without pregnancy preventive.
    Villarejos VM; Arguedas JA; Hernandez GC; Buynak EB; Hilleman MR
    Obstet Gynecol; 1973 Nov; 42(5):689-95. PubMed ID: 4749573
    [No Abstract]   [Full Text] [Related]  

  • 30. Rubella antibody titres, rubella vaccination, and the obstetrician.
    Giles PF; Mackay-Scollay EM; Christiansen K
    Aust N Z J Obstet Gynaecol; 1973 May; 13(2):65-71. PubMed ID: 4518717
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of a vaccination programme on the distribution of rubella antibodies in women of childbearing age.
    Hambling MH
    Lancet; 1975 May; 1(7916):1130-3. PubMed ID: 49484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rubella embryopathy, still now? (author's transl)].
    Enders G
    Geburtshilfe Frauenheilkd; 1982 May; 42(5):403-13. PubMed ID: 6921121
    [No Abstract]   [Full Text] [Related]  

  • 33. Rubella immunization.
    Weinstein L; Chang TW
    N Engl J Med; 1973 Jan; 288(2):100-1. PubMed ID: 4344403
    [No Abstract]   [Full Text] [Related]  

  • 34. Rubella antibody titers in vaccinated and nonvaccinated women and results of vaccination during pregnancy.
    Enders G
    Rev Infect Dis; 1985; 7 Suppl 1():S103-7. PubMed ID: 4001718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
    Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
    Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Susceptibility of pregnant women to rubella and the implications of immunization programs].
    Villalbí JR; Graells C; Marín T
    An Esp Pediatr; 1988 Feb; 28(2):137-40. PubMed ID: 3355032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guide to the management of rubella problems.
    Middleton PJ; Larke RP; Lessard P; Doran TA
    Can Med Assoc J; 1977 Mar; 116(5):484-8. PubMed ID: 837313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated rubella virus vaccine in women. Clinical trials during the postpartum period.
    Boué A; Papiernick-Berkhauer E; Lévy-Thierry S
    Am J Dis Child; 1969 Aug; 118(2):230-3. PubMed ID: 4893823
    [No Abstract]   [Full Text] [Related]  

  • 39. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K; Nategh R; Ahangary S; Mohsenin H
    Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
    [No Abstract]   [Full Text] [Related]  

  • 40. Late seroconversion following HPV-77, DE5 rubella virus vaccine.
    Wilkins J
    Am J Obstet Gynecol; 1975 Apr; 121(7):998-1002. PubMed ID: 1115189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.